Objective: This study aimed to compare the survival outcomes between trimodal therapy (TT) and partial cystectomy (PC) in muscle-invasive bladder cancer (MIBC) patients. Methods: The data of 13,096 patients with MIBC diagnosed between 2004 and 2015 were retrieved from the Surveillance, Epidemiology, and End Results database. Among them, 4,041 patients underwent TT and 1,670 patients underwent PC. Propensity score matching was performed to balance the characteristics between the 2 treatment groups. A multivariate Cox regression analysis model and a competing risk model were used to evaluate overall survival (OS) and cancer-specific survival. Cumulative incidence survival curves were obtained using the Kaplan-Meier method. Results: Results of multivariate Cox analysis before propensity score matching showed that the TT group had a 31% reduction in cause-specific survival relative to the PC group (HR: 0.69, 95% CI: 0.61–0.78, p < 0.001) and a 28% reduction in OS (HR: 0.72, 95% CI: 0.66–0.79, p < 0.001). After propensity score matching, the 2 groups yielded 972 patients, with 3-year cause-specific survival rates of 54.1% and 68.5% in the TT group and the PC group, respectively. Conclusions: Patients who underwent PC had a better prognosis than those who received TT. In addition, for MIBC patients who required bladder-sparing therapy, advanced age (≥80 years), pathological type of squamous cell carcinoma, and tumor stage of T3–4, N2–3, and M1 were independent poor prognostic factors.

1.
Siegel
RL
,
Miller
KD
,
Jemal
A
.
Cancer statistics, 2020
.
CA Cancer J Clin
.
2020 Jan
;
70
(
1
):
7
30
.
2.
Lin
T
,
Li
K
,
Liu
H
,
Xue
X
,
Xu
N
,
Wei
Y
,
.
Enhanced recovery after surgery for radical cystectomy with ileal urinary diversion: a multi-institutional, randomized, controlled trial from the Chinese bladder cancer consortium
.
World J Urol
.
2018
;
36
(
1
):
41
50
.
3.
Gakis
G
,
Efstathiou
J
,
Lerner
SP
,
Cookson
MS
,
Keegan
KA
,
Guru
KA
,
.
ICUD-EAU international consultation on bladder cancer 2012: radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder
.
Eur Urol
.
2013
;
63
(
1
):
45
57
.
4.
Leveridge
MJ
,
Siemens
DR
,
Mackillop
WJ
,
Peng
Y
,
Tannock
IF
,
Berman
DM
,
.
Radical cystectomy and adjuvant chemotherapy for bladder cancer in the elderly: a population-based study
.
Urology
.
2015
;
85
(
4
):
791
8
.
5.
Milowsky
MI
,
Rumble
RB
,
Booth
CM
,
Gilligan
T
,
Eapen
LJ
,
Hauke
RJ
,
.
Guideline on muscle-invasive and metastatic bladder cancer (European Association of Urology guideline): American Society of Clinical Oncology clinical practice guideline endorsement
.
J Clin Oncol
.
2016
;
34
(
16
):
1945
52
.
6.
Arcangeli
G
,
Arcangeli
S
,
Strigari
L
.
A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC)
.
Crit Rev Oncol Hematol
.
2015
;
94
(
1
):
105
15
.
7.
Smith
ZL
,
Christodouleas
JP
,
Keefe
SM
,
Malkowicz
SB
,
Guzzo
TJ
.
Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy
.
BJU Int
.
2013
;
112
(
1
):
13
25
.
8.
Koga
F
,
Kihara
K
,
Yoshida
S
,
Yokoyama
M
,
Saito
K
,
Masuda
H
,
.
Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients
.
BJU Int
.
2012
;
109
(
6
):
860
6
.
9.
Singletary
SE
,
Greene
FL
,
Sobin
LH
.
Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on cancer staging manual
.
Cancer
.
2003
;
98
(
12
):
2740
1
.
10.
Bruins
HM
,
Veskimae
E
,
Hernandez
V
,
Imamura
M
,
Neuberger
MM
,
Dahm
P
,
.
The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review
.
Eur Urol
.
2014
;
66
(
6
):
1065
77
.
11.
Hautmann
RE
,
de Petriconi
RC
,
Pfeiffer
C
,
Volkmer
BG
.
Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients
.
Eur Urol
.
2012
;
61
(
5
):
1039
47
.
12.
Moschini
M
,
Luzzago
S
,
Zaffuto
E
,
Dell’Oglio
P
,
Gandaglia
G
,
Mattei
A
,
.
The surgical management of patients with clinical stage T4 bladder cancer: a single institution experience
.
Eur J Surg Oncol
.
2017
;
43
(
4
):
808
14
.
13.
Krishna
SR
,
Konety
BR
.
Current concepts in the management of muscle invasive bladder cancer
.
Indian J Surg Oncol
.
2017
;
8
(
1
):
74
81
.
14.
Grubmueller
B
,
Seitz
C
,
Shariat
SF
.
The treatment of muscle-invasive bladder cancer in geriatric patients
.
Curr Opin Urol
.
2016
;
26
(
2
):
160
4
.
15.
Rose
TL
,
Milowsky
MI
.
Management of muscle-invasive bladder cancer in the elderly
.
Curr Opin Urol
.
2015
;
25
(
5
):
459
67
.
16.
Stein
JP
,
Lieskovsky
G
,
Cote
R
,
Groshen
S
,
Feng
AC
,
Boyd
S
,
.
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients
.
J Clin Oncol
.
2001
;
19
(
3
):
666
75
.
17.
Shabsigh
A
,
Korets
R
,
Vora
KC
,
Brooks
CM
,
Cronin
AM
,
Savage
C
,
.
Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology
.
Eur Urol
.
2009
;
55
(
1
):
164
74
.
18.
Soria
F
,
Moschini
M
,
Wirth
GJ
,
Gust
KM
,
Klatte
T
,
Briganti
A
,
.
Characterization of late recurrence after radical cystectomy in a large multicenter cohort of bladder cancer patients
.
Urology
.
2017
;
106
:
119
24
.
19.
Given
RW
,
Parsons
JT
,
McCarley
D
,
Wajsman
Z
.
Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: a five-year follow-up
.
Urology
.
1995
;
46
(
4
):
499
5
; discussion 504–5. http://dx.doi.org/10.1016/S0090-4295(99)80262-3.
20.
Mak
RH
,
Hunt
D
,
Shipley
WU
,
Efstathiou
JA
,
Tester
WJ
,
Hagan
MP
,
.
Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233
.
J Clin Oncol
.
2014
;
32
(
34
):
3801
9
.
21.
Arcangeli
G
,
Strigari
L
,
Arcangeli
S
.
Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: a systematic review of clinical trials
.
Crit Rev Oncol Hematol
.
2015
;
95
(
3
):
387
96
.
22.
Novick
AC
,
Stewart
BH
.
Partial cystectomy in the treatment of primary and secondary carcinoma of the bladder
.
J Urol
.
1976
;
116
(
5
):
570
4
.
23.
Kaneti
J
.
Partial cystectomy in the management of bladder carcinoma
.
Eur Urol
.
1986
;
12
(
4
):
249
52
.
24.
Evans
RA
,
Texter
JH
Jr
.
Partial cystectomy in the treatment of bladder cancer
.
J Urol
.
1975
;
114
(
3
):
391
3
.
25.
Herr
HW
.
Transurethral resection of muscle-invasive bladder cancer: 10-year outcome
.
J Clin Oncol
.
2001
;
19
(
1
):
89
93
.
26.
Fahmy
O
,
Khairul-Asri
MG
,
Schubert
T
,
Renninger
M
,
Malek
R
,
Kübler
H
,
.
A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer
.
Urol Oncol
.
2018
;
36
(
2
):
43
53
.
27.
Seisen
T
,
Sun
M
,
Lipsitz
SR
,
Abdollah
F
,
Leow
JJ
,
Menon
M
,
.
Comparative effectiveness of trimodal therapy versus radical cystectomy for localized muscle-invasive urothelial carcinoma of the bladder
.
Eur Urol
.
2017
;
72
(
4
):
483
7
.
28.
Solsona
E
,
Iborra
I
,
Collado
A
,
Rubio-Briones
J
,
Casanova
J
,
Calatrava
A
.
Feasibility of radical transurethral resection as monotherapy for selected patients with muscle invasive bladder cancer
.
J Urol
.
2010
;
184
(
2
):
475
80
.
29.
Grossman
HB
,
Natale
RB
,
Tangen
CM
,
Speights
VO
,
Vogelzang
NJ
,
Trump
DL
,
.
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer
.
N Engl J Med
.
2003
;
349
(
9
):
859
66
.
You do not currently have access to this content.